Tessa Therapeutics Pte Ltd

47 articles about Tessa Therapeutics Pte Ltd

• Distinguished Breast Cancer Expert, Dr. George W. Sledge, Jr., M.D., to join the Board of Tessa Therapeutics

  12/21/2018

  Dr. George W. Sledge, Jr., M.D., is Professor and Chief of Medical Oncology at the Stanford University Medical Center

• 

  BioSpace Movers and Shakers for Dec. 3

  12/3/2018

  Biotechs and pharmas strengthened their leadership teams with these appointments. Find news from Mersana, Foamix, Allergan, and more.

• Vineti™ to Partner With Tessa Therapeutics™ to Advance and Scale Cancer Immunotherapies World-Wide

  11/22/2018

  Vineti’s software platform for cell therapy workflows will support Tessa’s Asia operations and global capabilities, help scale transformative research in personalized cell therapies for solid tumors, and transition to commercial operations

• St. Jude Children's Research Hospital and Tessa Therapeutics Announce Strategic Collaboration

  9/21/2018

  The collaboration between St. Jude and Tessa aims to advance cellular immunotherapy treatments for childhood cancer

• Tessa Therapeutics Announces Opening of Recruitment Sites Across the United States for its Phase III Nasopharyngeal Cancer Immunotherapy Trial

  2/5/2018

  The first T cell infusion under the trial in the U.S. was carried out at City of Hope National Medical Center.

• 

  Tessa Therapeutics Lands $80M Financing to Advance Clinical Pipeline

  12/20/2017

  The $80M financing round led by Temasek and joined by EDBI, Karst Peak Capital, Heliconia, Heritas and other investors.

• Tessa Therapeutics Appoints Mr. Desmond Lim as CFO

  12/12/2017

  Mr. Lim has over 25 years of finance experience and has held multiple senior executive roles in the recent decade.